MARATTO

article · Health Science Reports

Prevalence of malaria parasitaemia among pregnant women at booking in Nigeria

202320 citationsOpen accessUniversity College Hospital, Ibadan

Abstract

Abstract Background Malaria is a major public health concern among pregnant women in sub‐Saharan Africa. Within the region, Nigeria has the highest malaria cases. This study aimed to determine the prevalence and factors associated with malaria parasitaemia among pregnant women at a booking clinic in Ibadan, Nigeria. Methods A cross‐sectional study was conducted between January and April 2021 at the University College Hospital in Ibadan, Nigeria. A sample of 300 pregnant women participated, and anaemia and malaria were diagnosed using packed cell volume and Giemsa‐stained blood smears, respectively. Data analysis was done using SPSS 25.0. Results The study found that 26 (8.70%) pregnant women tested positive for malaria parasitaemia. Factors such as age, religion, level of education, and occupation were significantly related to the prevalence of malaria parasitaemia among pregnant women with p < 0.05. Conclusion Our study identified a high prevalence of malaria parasitaemia among pregnant women with demographic factors such as age, religion, level of education, and occupation significantly associated. Targeted malaria control interventions for pregnant women with low levels of education and low‐income occupations are necessary, with more research needed to evaluate their effectiveness.

Research topics

  • Malaria Research and Control
  • Parasitic Diseases Research and Treatment
  • Parasites and Host Interactions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/hsr2.1337

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.